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SUMMARY
Background
Lymphoid aggregates are normally found throughout the small and large intestine.
Known as lymphoid nodular hyperplasia (LNH), these aggregates are observed espe-
cially in young children and are not associated with clinical symptoms being consid-
ered ‘physiological’. In children presenting with gastrointestinal symptoms the number
and size of the lymphoid follicles are increased. Patients suffering from gastrointestinal
symptoms (i.e. recurrent abdominal pain) should systematically undergo gastroduode-
noscopy and colonoscopy. With these indications LNH, especially of the upper but
also of the lower gastrointestinal tract has been diagnosed, and in some children it
may reﬂect a food hypersensitivity (FH) condition.
Aim
To review the literature about the relationship between LNH and FH, particularly
focusing on the diagnostic work-up for LNH related to FH.
Methods
We reviewed literature using Pubmed and Medline, with the search terms ‘lymphoid
nodular hyperplasia’, ‘food hypersensitivity’, ‘food allergy’ and ‘food intolerance’. We
overall examined 10 studies in detail, selecting articles about the prevalence of LNH in
FH patients and of FH in LNH patients.
Results
Collected data showed a median of 49% (range 32–67%) LNH in FH patients and a
median of 66% (range 42–90%) FH in LNH patients. Literature review pointed out
that the most important symptom connected with LNH and/or FH was recurrent
abdominal pain, followed by diarrhoea and growth retardation. Both LNH and FH are
associated with an increase in lamina propria c/d+ T cells, but the mechanisms by
which enhanced local immune responses causing gastrointestinal symptoms still
remain obscure.
Conclusions
When assessing FH, we rely on clinical evaluation, including elimination diet and
challenge tests, and endoscopic and immunohistochemical ﬁndings. Considering the
possible co-existence of duodenal and ileo-colonic LNH, upper endoscopy can be rec-
ommended in children with suspected FH, especially in those presenting with addi-
tional upper abdominal symptoms (i.e. vomiting). Likewise, lower endoscopy might be
additionally performed in patients with suspected FH and LNH of the duodenal bulb,
also presenting with lower abdominal symptoms (i.e. recurrent abdominal pain).
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LYMPHOID NODULAR HYPERPLASIA: FROM
PHYSIOLOGY TO PATHOLOGY
Lymphoid follicles, with or without germinal centres, are
normally found throughout the small and large intestine.
In the terminal ileum these coalesce to form Peyer’s
patches. In the colon, the number of lymphoid structures
increases from the caecum to the rectum. Lymphoid tis-
sue is particularly prominent in the anorectal region, just
above the dentate line of the anal canal.1, 2 However, a
high ‘density’ of lymphoid follicles could indicate a path-
ological condition. In this review, in accordance with
previous published works, lymphoid nodular hyperplasia
(LNH) was deﬁned as a cluster of >10 extruding lym-
phoid nodules, whereas a lymphoid nodule was deﬁned
as an extruding lymphoid follicle with a diameter of
 2 mm.3
In the gastrointestinal tract, the key step to antigen
processing, evolving either into oral tolerance or a strong
immune response against antigens administered orally,
involves its initial uptake from the gut lumen by specia-
lised follicle-associated epithelium called ‘M’ cells. M
cells originate from adjacent crypt epithelium and are
interspersed between the absorptive epithelial cells in the
follicle-associated epithelium. These cells take up macro-
molecules, viruses, bacteria and protozoa within 30 min
from the initial presentation of the antigen in the intesti-
nal lumen. After the initial uptake of antigen by M cells,
the antigens are transported into the follicular areas to
be processed by dendritic cells and brought into close
contact with the antigen-speciﬁc precursors for IgA-
secreting plasma cells. The ﬁnal result of M-cell process-
ing is the production of a vigorous secretory IgA
response and local cell-mediated immunity with suppres-
sion of a systemic IgG, IgE and delayed-type hypersensi-
tivity to orally administered antigens.4
Lymphoid nodular hyperplasia presents endoscopically
as smooth, yellow-white nodules up to 2 mm in diame-
ter. They are observed more frequently in young chil-
dren and are not associated with clinical symptoms, in
which form LNH is considered to be ‘physiological’. In
children presenting with gastrointestinal symptoms, i.e.
abdominal pain and rectal bleeding, the number and size
of lymphoid follicles is increased and the anatomical
distribution of enlarged lymphoid aggregates is age-
dependent. It has been demonstrated that upper gastro-
intestinal symptoms in children could be related to food
allergy. However, it is also known that the prevalence of
food allergy declines with increasing age in adult life
and this could be linked to the marked decrease in
number of Peyer’s patches and in LNH. In addition,
adult subjects showing LNH at endoscopy examination
have been reported to suffer more frequently from food
allergy.5
Intestinal LNH has also been associated with viral and
bacterial infection and immune deﬁciency status, thus it
exists as both a physiological and as a pathological
lesion.6 For example, Khuroo et al. studied 40 patients
with Heliobacter pylori and duodenal LNH. Video cap-
sule endoscopies revealed nodular disease exclusively
limited to the duodenum. Sequential antibiotic therapy
eradicated H. pylori infection in 26 patients. Follow-up
duodenoscopy in these patients showed a signiﬁcant
reduction in the duodenal nodular lesions score (i.e.
complete resolution in ﬁve patients and signiﬁcant reso-
lution in the remaining 21 patients). The patients with
resistant H. pylori infection showed no signiﬁcant reduc-
tion in the nodular lesions score.7 Finally, LNH is not
always benign, and may be associated with intussuscep-
tion8 or even fatal colonic torsion.9 Thus, acute onset
abdominal pain in a child with documented LNH or
intestinal food allergy should warrant early surgical
assessment.
LNH AND FOOD HYPERSENSITIVITY
Food hypersensitivity (FH) is the umbrella term used to
describe both food allergy, which involves the immune
system (i.e. IgE and non-IgE-mediated mechanisms), as
well as food intolerances, which do not.10
Food hypersensitivity may produce a wide variety of
patchy or diffuse mucosal lesions in any part of the gas-
trointestinal tract, depending on the genetic characteris-
tics of the subject and the type of the intervening
immunological reaction. The changes may manifest clini-
cally as buccal rash, aphthous wounds of the oral cavity,
gastro-oesophageal reﬂux or oesophagitis, gastritis in the
stomach, villous atrophy in the small intestine or colitis
and may ﬁnally appear as an itchy rash around the anus.
Although most of the lesions are limited to certain areas,
the changes may occasionally spread throughout the
whole gastrointestinal tract, a condition which is very
often characterised by eosinophilic mucosal inﬁltrate and
is termed ‘eosinophilic gastroenteropathy’.11, 12
Food hypersensitivity in infants is more often general-
ised, with symptoms of dermatitis and/or mucosal reac-
tions of the respiratory tract to corresponding allergies.
In school-age children or adults, in whom gastrointesti-
nal symptoms are more prominent, symptoms vary from
malabsorption with loose stools or growth retardation
and anaemia, to regurgitation, discomfort and abdominal
pain and constipation.13
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The diagnosis is nowadays based on elimination diets
and on repeated open oral provocation tests, but the
‘gold diagnostic standard’ is the double-blind placebo-
controlled challenge.14
As most subjects with FH are examined only for the
main and more severe symptoms, the overall extent and
macroscopic and histological characteristics of the related
lesions have often remained obscure. In particular,
infants and children with FH have not been systemati-
cally scheduled for endoscopic examination. Knowledge
of mucosal abnormalities has been based on small intes-
tinal biopsies from limited selected patient series. Colo-
noscopy has also been indicated in selected patients with
severe chronic or recurrent abdominal pain, or present-
ing with chronic constipation refractory to laxative ther-
apy or blood in stools. With these indications LNH,
especially of the mucosa of the upper gastrointestinal
tract (i.e. duodenal bulb), has been diagnosed and in
some children it may reﬂect a condition of overt FH. On
the other hand, it must be underlined that in most of
these studies, the diagnosis of FH was not properly man-
aged (nonblinded, not placebo-controlled). However,
previous reports have demonstrated this lesion in
patients without FH, presenting with common variable
immunodeﬁciency, hypogammaglobulinaemia, IgA deﬁ-
ciency, HIV infection, HP infection, giardiasis, juvenile
idiopathic arthritis and connective tissue disease or intes-
tinal malignant lymphoma, as well as in healthy sub-
jects.15–23
LNH OF THE DUODENAL BULB
Some studies have demonstrated a signiﬁcant association
between FH and LNH distributed diffusely on the duo-
denal bulb. Lymphoid nodules on the duodenal mucosa
are distinctly more numerous in subjects with FH than
in patients in whom any other state or coeliac disease is
diagnosed. FH in duodenal LNH subjects was mostly of
the gastrointestinal type. Even at onset it manifested with
symptoms of vomiting or recurrent abdominal pain, and
after oral challenge gastrointestinal symptoms were the
ﬁrst to be manifested, although in some patients derma-
titis was exacerbated later on. Moreover, in most duode-
nal LNH patients it is not possible to demonstrate atopic
allergy by skin prick tests or elevated serum IgE values.
Thus, the patients with duodenal bulb LNH mostly pres-
ent a local reactivity of delayed-type FH.15, 16
It has been also demonstrated that an intensive
humoral immune response to cow’s milk proteins and
their fractions may be associated with gastrointestinal
symptoms (i.e. recurrent abdominal pain) and duodenal
LNH, even in children over the age of 3 years. Endo-
scopic ﬁndings in these patients included local and pat-
chy hyperplasia of the lymphoid tissue and
immunological evidence showed that the untreated cow’s
milk allergy children had signiﬁcantly higher levels of
IgA and IgG class antibodies to whole cow’s milk and its
speciﬁc fractions than age-matched controls.24
Cow’s milk allergy can also exist in school-age chil-
dren. Moreover, there is increasing evidence that this
allergy may also be a common problem in young adults
with undeﬁned and prolonged gastrointestinal com-
plaints. Both endoscopic and histological alterations are
most prominently found in the duodenum bulb, where
LNH or lymphoid follicles are commonly seen. As in
coeliac disease, the increase in c/d+ T-cells is characteris-
tic of cow’s milk allergy. However, unlike in coeliac dis-
ease, patients with cow’s milk allergy do not present
antiendomysium antibodies, HLA-DQ2 and -DQ8 geno-
types, abnormal HLA-DR expression or duodenal villous
changes. Taken together, these results indicate that the
mucosal changes are because of a different pathogenetic
mechanism in cow’s milk allergy than in coeliac disease.
Moreover, this histological picture cannot be considered
as precursor to coeliac disease, because its striking fea-
tures are mucosal lymphoid nodules with normal villous
architecture.25
ILEO-COLONIC LNH
Unlike duodenal LNH, LNH of the mucosa of the lower
gastrointestinal tract (i.e. terminal ileum and colon) in
children was for several years considered a serendipitous
ﬁnding without any clinical signiﬁcance, as an expression
of a mucosal response to nonspeciﬁc stimuli, most often
infection. It was consequently regarded as a pathophysio-
logical phenomenon during infancy and childhood, or,
in a lower percentage of cases, as a sign within the spec-
trum of inﬂammatory bowel diseases.26, 27
More recent studies3 have shown an elevated fre-
quency of colonic LNH in a large series of consecutive
children undergoing colonoscopy for various symptoms
(i.e. severe chronic or recurrent abdominal pain and
chronic constipation refractory to laxative therapy).
Colonic LNH was associated with other endoscopic and/
or histological ﬁndings pointing to a ﬁnal diagnosis of
IBD in a number of the cases. However, in the vast
majority of the patients, who had colonic LNH as the
sole endoscopic ﬁnding, an appropriate elimination diet
followed by food challenge with the offending food(s)
led to a diagnosis of FH. Cow’s milk was the only causa-
tive food protein in the majority of these cases, whereas
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multiple hypersensitivity was observed in the remaining
patients. In addition, as clinical symptoms reappeared
some days after the food challenge, it is clear that most
patients had a delayed-type reaction to the offending
food(s). The consistency of the association between FH
and colonic LNH was conﬁrmed by the fact that a much
lower number of patients without colonic LNH had FH.
The mean age of patients with isolated LNH and FH
was 7.5 years, thus supporting previous studies showing
that FH might persist or manifest itself in school-age
children and in adults.25, 28, 29
In agreement with previous reports on the frequency
of colonic LNH in both children and adult patients with
haematochezia,30, 31 gastrointestinal bleeding was present
with a signiﬁcantly higher frequency in the children with
isolated colonic LNH and FH than in the whole study
groups.
In adults suffering from recurrent rectal bleeding, we
demonstrated that LNH not associated to other endo-
scopic signs was very often caused by multiple food
hypersensitivity.31 In these patients, the clinical history of
the allergic patients showed that abdominal pain and
bowel habit disturbances very often accompanied the rec-
tal bleeding. It was noteworthy that very often these
patients had undergone multiple investigations in the past
but without any diagnoses, although the patients them-
selves often had self-reported a food intolerance, but this
was not considered by the clinicians who treated them. It
is very probable that the negativity of the IgE-mediated
assays in these patients had contributed to a not corrected
diagnosis, but it is known that most of the gastrointestinal
symptoms caused by food hypersensitivity cannot be cor-
rectly diagnosed on the basis of these assays.
Other symptoms associated with endoscopic evidence
of isolated colonic LNH were anaemia and growth deﬁ-
ciency, recently recognised as part of the clinical spec-
trum of FH.32 Both the humoral and histological
ﬁndings strongly suggest that colonic LNH is a sensitive
endoscopic marker of FH, most likely related to a cell-
mediated immune response. In fact, there was a signiﬁ-
cantly higher number of patients with elevated serum
anti-b-lactoglobulin IgG in the colonic LNH group, in
accordance with previous reports on FH with gastroin-
testinal manifestations and with the known allergenicity
of b-lactoglobulin, which is the main allergen in cow’s
milk.24, 33, 34
Iacono et al.3 and Turunen et al.35 demonstrated that
among children with chronic constipation refractory to
laxative therapy some actually have cow’s milk hypersen-
sitivity, with characteristic endoscopic and histological
ﬁndings (i.e. LNH) and elevated densities of c/d+ T-cells.
This was also strongly supported by the subsidence of
constipation or other symptoms during milk elimination
and the relapse of original symptoms during the chal-
lenge. Ileo-colonic LNH was present in most of the sub-
jects with chronic constipation because of FH and was
most prominent in the terminal ileum and transverse
colon. In the duodenum bulb, the lesion was also found
in many subjects on gastroduodenoscopy. The authors
also found an increased density of intraepithelial c/d+ T-
cells in biopsy samples from the terminal ileum. There-
fore, a diagnostic workup in a child with suspected cow’s
milk-related constipation should include a careful clinical
assessment with a milk elimination trial and a long chal-
lenge. Endoscopic examinations with biopsies and immu-
nohistochemical studies may help to establish the
diagnosis and exclude other conditions.
Finally, Kokkonen et al.36 suggested a strong associa-
tion between ileo-colonic LNH and FH. In particular,
they showed that LNH is a common endoscopic bystan-
der on the mucosa of the lower gastrointestinal tract.
Their results supported the view that this is not just a
silent ﬁnding but is related to enhanced immunological
activity, with FH being the most common underlying
state, especially in the case of colonic LNH. Indeed, its
presence on the mucosa of the colon indicated an associ-
ation with FH similar to that in the duodenal bulb. If
present on the mucosa of the terminal ileum, immune-
mediated disorders other than FH (i.e. inﬂammatory
bowel diseases) may also have produced the lesion. Thus,
children diagnosed with LNH of the lower gastrointesti-
nal tract (especially of the colon) should be carefully
assessed for the possibility of hypersensitivity to basic
foodstuffs by whatever techniques are appropriate,
including oral challenge. In addition, according to the
above study,35 most of the patients with LNH related to
FH showed similar lesions on the mucosa of the duode-
num. Of note, the coexistence of LNH in these two loca-
tions could not be demonstrated in all patients,
conﬁrming the view that FH in children may produce
patchy or diffuse LNH in any part of the gastrointestinal
tract. LNH of the colon was even seen in children diag-
nosed for FH being treated with an elimination diet,
which supports the view that the increase in lymphoid
tissue persists even after the triggering foodstuffs have
been eliminated. The same was found in the duodenum.
Tables 1 and 2 summarised the study regarding LNH
and FH. Figure 1 shows a typical picture of colonic LNH
in a patient suffering from FH, diagnosed at the ‘Di Cri-
stina’ Pediatric Hospital of Palermo.
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LNH AND DENSITY OF c/d+ T-CELLS
An increase in the density of c/d+ T-cell receptor-bear-
ing intraepithelial lymphocytes is considered to be spe-
ciﬁc to gluten-sensitive enteropathy, although it must be
recognised that the real role of c/d+ T-cells in this dis-
ease is still enigmatic (i.e. they may remain elevated even
on a gluten-free diet or decrease on elimination diet). In
addition, their normal density has not yet been precisely
determined.37, 38 The connection between intraepithelial
c/d+ T-cells and other members of innate immunity are
highlighted by the results of Kokkonen et al., who
recently demonstrated in coeliac disease and in cow’s
milk-sensitive enteropathy that serum CD23, a protein
expressed in the lymphoid follicles, tends to increase. In
coeliac disease, serum CD23 levels may provide informa-
tion about the severity of villous atrophy, whereas in
cow’s milk-sensitive enteropathy high serum FasL, func-
tionally connected with IL-15 proliferation and apoptosis
of the intraepithelial lymphocytes, indicates an increase
in intraepithelial lymphocytes and the presence of LNH,
suggesting the importance of FasL-mediated mechanisms
in the pathogenesis of these cow’s milk-sensitive enterop-
athy features.39
However, in children with FH and LNH of the duode-
num bulb it is possible to demonstrate a higher than
normal density of c/d+ intraepithelial lymphocytes,
together with a higher density of IFN-c positive cells in
the lamina propria and a higher proportion of crypt cells
in mitosis, as well as a rise in intraepithelial c/d+ T-cells
in untreated FH, whereas patients on an elimination diet
at the time of the examination show low counts. Thus,
c/d+ T-cells, which are considered to be markers of FH,
Table 2 | Food hypersensitivity (FH) in lymphoid nodular hyperplasia (LNH) patients
Text
reference Authors Clinical presentation
Cases
number
Age
(years
range)
Cases number and %
of patients affected
with LNH
Cases number and % of
patients affected with FH
10 Kokkonen J Recurrent abdominal
pain
63 1.9–15 12/63 (19%) 9/12 (75%)
23 Iacono G Severe chronic or
recurrent abdominal
pain, constipation,
diarrhoea, bloody
diarrhoea, growth
retardation, chronic
vomiting
245 3–10 Total: 73/245 (30%)
Isolated LNH
without IBD:
52/245 (21.2%)
Total FH: 103/245 (42%)
FH with isolated LNH
without IBD: 43/52 (83%)
27 Carroccio A Rectal bleeding 64 18–79 10/64 (16%) 9/10 with LNH (90%)
32 Kokkonen J Chronic colitis, IBD,
systemic vasculitis
140 3–16 Colonic LNH:
46/140 (33%)
36 without colitis (26%)
9 with colitis (6%)
2 with Crohn (0.7%)
Ileocolonic LNH:
50/74 (67%)
35 without colitis (47%);
13 with colitis (17%);
2 with Crohn (3%).
Duodenal bulb LNH:
22/102 (22%)
Colonic LNH:
25/46 (54%)
Ileocolonic LNH:
18/50 (36%)
Duodenal bulb LNH:
13/22 (59%)
Figure 1 | Typical picture of colonic lymphoid nodular
hyperplasia in a patient suffering from food
hypersensitivity.
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seem to react more rapidly during dietary therapy and
only increase in active and untreated cases. LNH could
represent a more long-standing or even permanent up-
regulation of immunological response to food antigens,
persisting even after the deleterious antigen has been
removed from the diet.40–42 In this context, parental
assessments of a likely FH agreed with these mucosal
ﬁndings (increased intraepithelial T-cells and c/d+ cells)
in a signiﬁcant number of cases, even when food chal-
lenges were reportedly negative. In fact, food challenges
could be negative in FH patients, especially those with
non-IgE-mediated FH mechanisms.40
As regards to LNH of the terminal ileum, some
authors have demonstrated that this pathology is associ-
ated with increased densities of c/d+ T-cells, as in chil-
dren with LNH of the duodenal bulb and untreated FH.
Surprisingly, they found not only this association but
also a close association between an increase in these cells
and right-sided colitis and pancolitis. In contrast, neither
Crohn’s disease nor typical left-sided ulcerous colitis
showed any association. Thus, it would be possible to
classify colitis in children into c/d+ or ‘allergic’ and c/d-
or ‘non-allergic diseases’. The former seems to be an
entity starting from the terminal ileum as lymphoid
hyperplasia and continuing into the caecum as chronic
colitis, extending in a few cases as far as the rectum.
Clinically, this disease resembles what is traditionally
classiﬁed as ‘indeterminate colitis’. The other form of
colitis seems to start locally on the left side, probably on
the rectal mucosa, and extends proximally. Clinically,
this entity is compatible with typical ulcerous colitis. A
differential diagnosis might be made by simply counting
the density of c/d+ T-cells on the terminal ileum
mucosa. Thus, it seems evident that in Crohn’s disease
and left-sided colitis, different cytokine cascades and
pathogenetic mechanisms to those involved in right-
sided colitis become activated.43 These results are in
accordance with a number of previous studies suggesting
that Crohn’s disease with granulomas is a TH1- and/or
TH17-mediated disease.
44–46
At present, no immunohistochemical studies on colo-
nic biopsies are available of patients with colonic LNH,
either related or unrelated to FH.
Finally, the mechanisms by which the enhanced local
immune responses (i.e. LNH and c/d+ intraepithelial T-
cells) cause gastrointestinal symptoms remain mostly
obscure. FH symptoms have been suggested as being due
to a cytokine imbalance. Children with delayed-type
cow’s milk allergy showed lower IL-2 and IL-18 mRNA
expression in the duodenum and higher CCR-4 and IL-6
mRNA expression in the terminal ileum, compared with
controls and children with coeliac disease. The mRNA
expression levels of regulatory cytokines (i.e. transform-
ing growth factor-beta and IL-10) remained similar in
patients and controls. Children with delayed-type gastro-
intestinal cow’s milk allergy showed a unique pattern of
local intestinal hypersensitivity with TH2 response-
related characteristics, a proﬁle clearly differing from
those with coeliac disease.47, 48
LNH AND AUTISTIC DISORDERS
The autistic spectrum disorder, or ASD, is a neurodevel-
opmental disorder characterised by socially aloof behav-
iour and impairment of language and social interaction.
Gastrointestinal symptoms are described in 9–54% of
autistic children, the most common of which are consti-
pation, diarrhoea and abdominal distension. The gastro-
intestinal abnormalities reported in autism include
adverse reaction to foods (i.e. non-IgE-mediated FH),
inﬂammation (oesophagitis, gastritis, duodenitis, entero-
colitis), increased intestinal permeability, low activities of
disaccharidase enzymes, dysbiosis with bacterial over-
growth, impairment of detoxiﬁcation (i.e. defective sulf-
ation of ingested phenolic amines) and exorphin
intoxication (by opioids, i.e. caseomorphine and gluteo-
morphine derived from casein and gluten). A beneﬁcial
effect of dietary intervention on the behaviour and cog-
nition of some autistic children indicates a functional
relationship between the alimentary tract and the central
nervous system.49–51 However, this is a strongly contro-
versial issue and data contrasting with the above ﬁndings
have been published.52, 53
In addition to the above-mentioned gastrointestinal
abnormalities, some authors also demonstrated that sev-
eral ileo-colonic LNH in children with ASD, referred to
a gastroenterology clinic for chronic gastrointestinal
symptoms, warranted investigation by ileo-colonos-
copy.54–56 The ﬁndings were compared with control
groups of children who were developmentally normal.
Children with ASD are less likely to present with
abdominal pain and more likely to present with consti-
pation. However, this could reﬂect the relative inability
of children with autism to communicate the experience
of pain. The autistic children showed a higher frequency
of LNH in the terminal ileum (93% vs. 14.3%) and the
colon (30% vs. 3%).
If the data on gastrointestinal manifestations in
autistic children continue to mount, then the basis
for a link will need to be thoroughly investigated to
ascertain whether the intestinal and cognitive
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manifestations are merely different components of a
complex syndrome of unknown pathogenesis, or could
be causally related.
It is possible to hypothesise a primitive, poorly under-
stood immune dysfunction that predisposes autistic chil-
dren to a broad spectrum of immunologically based
disorders, i.e. eczema, upper respiratory tract infections,
FH, as well as ileo-colonic LNH. The impaired cognitive
function could then be explained on the basis of an
‘entero-colonic encephalopathy’, analogous to hepatic
encephalopathy. Speciﬁcally, the intestinal lesion results
in an increased intestinal permeability to exogenous pep-
tides of dietary origin, ultimately leading to the disrup-
tion of neuroregulatory mechanisms and normal brain
development. These possibilities should be investigated
further.49, 50, 57
Table 3 | Lymphoid nodular hyperplasia: aetiologies and diagnostic procedures
Aetiologies Diagnostic procedures
IgA deﬁciency Laboratory measurement of IgA level in the blood
Common variable
immunodeﬁciency
Low serum IgG concentration
Reduced serum concentrations of other immunoglobulins, i.e. IgA or IgM
Low CD4+ count, associated with a normal to increased CD8+ count
In vitro proliferative responses of peripheral blood lymphocytes
Deﬁcient cytokine production by peripheral blood lymphocytes
Evidence of noncaseating granulomas on imaging studies or biopsy
Food hypersensitivity Prick tests
Radioallergosorbent test (RAST)
Elimination diet and oral food challenge
Human immunodeﬁciency virus
(HIV) infection
HIV enzyme-linked immunosorbent assay (ELISA)
HIV Western blot test
Human T-cell lymphotropic viruses
(HTLV)-I & II infection
HTLV ELISA
HTLV Western blot test
Detection of proviral DNA by Polymerase Chain Reaction (PCR)
Quantitative PCR assay
Cytomegalovirus (CMV) infection Serological assays, i.e. CMV IgM and IgG antibodies by ELISA and Radio Immune Assay
(RIA)
CMV IgG avidity
Epstein-Barr Virus (EBV) Infection Serological assays for viral capsid antigen (IgG and IgM), early antigen (IgG) and EBV
nuclear antigen (IgG) antibodies
Yersinia enterocolitica infection Recovery of Yersinia from stool samples, blood and lymph nodes
Culture in Cefsulodin-Irgasan-Novobiocin (CIN) or MacConkey agar
Serodiagnosis by tube agglutination, ELISA and RIA
PCR, DNA microarray and immunohistochemical staining
to detect Y. enterocolitica DNA
Helicobacter pylori infection ELISA detection of H. pylori speciﬁc antibodies, IgG and IgM
Breath tests (i.e. urea breath tests)
Stool tests (detection of H. pylori proteins by ELISA)
Giardiasis Stool ova and parasites detection
Giardia stool antigen test
Juvenile idiopathic arthritis (JIA) History
Physical examination ﬁndings
Laboratory studies help to exclude underlying disorders, classify type of arthritis and
evaluate for extra-articular manifestations
Imaging of affected joints is usually indicated
Other connective diseases History
Physical examination ﬁndings
Non-organ-speciﬁc autoantibodies
Laboratory assays and imaging techniques to detect e type organ injury
Intestinal lymphoma Endoscopy and biopsy
Wireless video capsule camera
Abdominal computerised tomography (CT) with intravenous contrast
Arteriography of the intestinal arteries (in case of tumour bleeding)
Exploratory surgery
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CONCLUSION: A DIAGNOSTIC WORK-UP FOR LNH
RELATED TO FH
In the presence of LNH, demonstrated during upper and/
or lower endoscopy performed for severe gastrointestinal
symptoms, the possible aetiologies and the related diag-
nostic procedures are shown in Table 3, where we con-
sidered FH together with many other diseases. For
diagnostic purposes, the presence of lymphoid follicles in
the biopsy specimen and a rise in c/d+ T-cells alone
would not be sufﬁcient in patients with suspected FH
showing endoscopic picture of LNH of the duodenal bulb
and/or of the terminal ileum and the colon. The diagnos-
tic problem is the patchy nature of all these signs, as they
can be dispersed at any one site along the gastrointestinal
tract from the oral cavity to the anus. In addition, there
is a signiﬁcant lack of serological markers for a diagnostic
assessment of mucosal abnormality. At present, when
clinically assessing FH, we rely on a clinical evaluation,
including a lengthy elimination diet and challenge tests,
together with endoscopic and/or immunohistochemical
ﬁndings as a sign of enhanced immune activity.
Considering the possible co-existence of duodenal and
ileo-colonic LNH, upper endoscopy can also be recom-
mended in children with suspected FH and ileo-colonic
LNH, especially in those presenting with additional
upper abdominal symptoms (i.e. vomiting and dyspep-
sia). Likewise, lower endoscopy might be additionally
performed in patients with suspected FH and endoscopi-
cally diagnosed LNH of the duodenal bulb also present-
ing with lower abdominal symptoms (i.e. severe chronic
or recurrent abdominal pain, or chronic constipation
refractory to laxative therapy or presence of blood in
stools).40
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